Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
Novel activating receptors of the lg super-family expressed on human myeloid cells, called TREM(s) (triggering receptor expressed on myeloid cells) are provided. Specifically, two (2) members of TREMs, TREM-1 and TREM-2 are disclosed. TREM-1 is a transmembrane glycoprotein expressed selectively on b...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | COLONNA MARCO STENNICKE VIBEKE W HENRIKSEN ANETTE BOUCHON AXEL SALBO RUNE ANDERSEN METTE D WIBERG CHARLOTTE |
| description | Novel activating receptors of the lg super-family expressed on human myeloid cells, called TREM(s) (triggering receptor expressed on myeloid cells) are provided. Specifically, two (2) members of TREMs, TREM-1 and TREM-2 are disclosed. TREM-1 is a transmembrane glycoprotein expressed selectively on blood neutrophils and a subset of monocytes but not on lymphocytes and other cell types and is upregulated by bacterial and fungal products. Use of TREM-1 in treatment and diagnosis of various inflammatory diseases is also provided. TREM-2 is also a transmembrane glycoprotein expressed selectively on mast cells and peripheral dendritic cells (DCs) but not on granulocytes or monocytes. DC stimulation via TREM-2 leads to DC maturation and resistance to apoptosis, and induces strong upregulation of CCR7 and subsequent chemotaxis toward macrophage inflammatory protein 3- . TREM-2 has utility in modulating host immune responses in various immune disorders, including autoimmune diseases and allergic disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8981061B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8981061B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8981061B23</originalsourceid><addsrcrecordid>eNqNyrEKwjAURuEsDqK-wx11EKyC1FWpuIhQ61xC8jcGYhLujaBv76K70xm-M1aXFga5JKaubc40L-ydA_voiH-CV2aIwFKK9HgjJG_JIARZkI6WngKhcgcjDVM1GnQQzL6dKDo23eG0RE49JGuDiNLfrvWurlbbar_e_LF8ALFgNkM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof</title><source>esp@cenet</source><creator>COLONNA MARCO ; STENNICKE VIBEKE W ; HENRIKSEN ANETTE ; BOUCHON AXEL ; SALBO RUNE ; ANDERSEN METTE D ; WIBERG CHARLOTTE</creator><creatorcontrib>COLONNA MARCO ; STENNICKE VIBEKE W ; HENRIKSEN ANETTE ; BOUCHON AXEL ; SALBO RUNE ; ANDERSEN METTE D ; WIBERG CHARLOTTE</creatorcontrib><description>Novel activating receptors of the lg super-family expressed on human myeloid cells, called TREM(s) (triggering receptor expressed on myeloid cells) are provided. Specifically, two (2) members of TREMs, TREM-1 and TREM-2 are disclosed. TREM-1 is a transmembrane glycoprotein expressed selectively on blood neutrophils and a subset of monocytes but not on lymphocytes and other cell types and is upregulated by bacterial and fungal products. Use of TREM-1 in treatment and diagnosis of various inflammatory diseases is also provided. TREM-2 is also a transmembrane glycoprotein expressed selectively on mast cells and peripheral dendritic cells (DCs) but not on granulocytes or monocytes. DC stimulation via TREM-2 leads to DC maturation and resistance to apoptosis, and induces strong upregulation of CCR7 and subsequent chemotaxis toward macrophage inflammatory protein 3- . TREM-2 has utility in modulating host immune responses in various immune disorders, including autoimmune diseases and allergic disorders.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150317&DB=EPODOC&CC=US&NR=8981061B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150317&DB=EPODOC&CC=US&NR=8981061B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COLONNA MARCO</creatorcontrib><creatorcontrib>STENNICKE VIBEKE W</creatorcontrib><creatorcontrib>HENRIKSEN ANETTE</creatorcontrib><creatorcontrib>BOUCHON AXEL</creatorcontrib><creatorcontrib>SALBO RUNE</creatorcontrib><creatorcontrib>ANDERSEN METTE D</creatorcontrib><creatorcontrib>WIBERG CHARLOTTE</creatorcontrib><title>Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof</title><description>Novel activating receptors of the lg super-family expressed on human myeloid cells, called TREM(s) (triggering receptor expressed on myeloid cells) are provided. Specifically, two (2) members of TREMs, TREM-1 and TREM-2 are disclosed. TREM-1 is a transmembrane glycoprotein expressed selectively on blood neutrophils and a subset of monocytes but not on lymphocytes and other cell types and is upregulated by bacterial and fungal products. Use of TREM-1 in treatment and diagnosis of various inflammatory diseases is also provided. TREM-2 is also a transmembrane glycoprotein expressed selectively on mast cells and peripheral dendritic cells (DCs) but not on granulocytes or monocytes. DC stimulation via TREM-2 leads to DC maturation and resistance to apoptosis, and induces strong upregulation of CCR7 and subsequent chemotaxis toward macrophage inflammatory protein 3- . TREM-2 has utility in modulating host immune responses in various immune disorders, including autoimmune diseases and allergic disorders.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAURuEsDqK-wx11EKyC1FWpuIhQ61xC8jcGYhLujaBv76K70xm-M1aXFga5JKaubc40L-ydA_voiH-CV2aIwFKK9HgjJG_JIARZkI6WngKhcgcjDVM1GnQQzL6dKDo23eG0RE49JGuDiNLfrvWurlbbar_e_LF8ALFgNkM</recordid><startdate>20150317</startdate><enddate>20150317</enddate><creator>COLONNA MARCO</creator><creator>STENNICKE VIBEKE W</creator><creator>HENRIKSEN ANETTE</creator><creator>BOUCHON AXEL</creator><creator>SALBO RUNE</creator><creator>ANDERSEN METTE D</creator><creator>WIBERG CHARLOTTE</creator><scope>EVB</scope></search><sort><creationdate>20150317</creationdate><title>Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof</title><author>COLONNA MARCO ; STENNICKE VIBEKE W ; HENRIKSEN ANETTE ; BOUCHON AXEL ; SALBO RUNE ; ANDERSEN METTE D ; WIBERG CHARLOTTE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8981061B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>COLONNA MARCO</creatorcontrib><creatorcontrib>STENNICKE VIBEKE W</creatorcontrib><creatorcontrib>HENRIKSEN ANETTE</creatorcontrib><creatorcontrib>BOUCHON AXEL</creatorcontrib><creatorcontrib>SALBO RUNE</creatorcontrib><creatorcontrib>ANDERSEN METTE D</creatorcontrib><creatorcontrib>WIBERG CHARLOTTE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COLONNA MARCO</au><au>STENNICKE VIBEKE W</au><au>HENRIKSEN ANETTE</au><au>BOUCHON AXEL</au><au>SALBO RUNE</au><au>ANDERSEN METTE D</au><au>WIBERG CHARLOTTE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof</title><date>2015-03-17</date><risdate>2015</risdate><abstract>Novel activating receptors of the lg super-family expressed on human myeloid cells, called TREM(s) (triggering receptor expressed on myeloid cells) are provided. Specifically, two (2) members of TREMs, TREM-1 and TREM-2 are disclosed. TREM-1 is a transmembrane glycoprotein expressed selectively on blood neutrophils and a subset of monocytes but not on lymphocytes and other cell types and is upregulated by bacterial and fungal products. Use of TREM-1 in treatment and diagnosis of various inflammatory diseases is also provided. TREM-2 is also a transmembrane glycoprotein expressed selectively on mast cells and peripheral dendritic cells (DCs) but not on granulocytes or monocytes. DC stimulation via TREM-2 leads to DC maturation and resistance to apoptosis, and induces strong upregulation of CCR7 and subsequent chemotaxis toward macrophage inflammatory protein 3- . TREM-2 has utility in modulating host immune responses in various immune disorders, including autoimmune diseases and allergic disorders.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US8981061B2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES SPIRITS VINEGAR WINE |
| title | Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T04%3A41%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COLONNA%20MARCO&rft.date=2015-03-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8981061B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |